- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 31/00 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patent holdings for IPC class A61P 31/00
Total number of patents in this class: 6524
10-year publication summary
|
279
|
245
|
348
|
492
|
422
|
514
|
483
|
435
|
338
|
171
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Mondobiotech Laboratories AG | 311 |
275 |
| Bristol-myers Squibb Company | 4893 |
65 |
| The Regents of the University of California | 19929 |
41 |
| Merck Patent GmbH | 5823 |
31 |
| Centre National de La Recherche Scientifique | 10432 |
29 |
| Agency for Science, Technology and Research | 3626 |
26 |
| The Johns Hopkins University | 5669 |
23 |
| The General Hospital Corporation | 4731 |
23 |
| Novartis AG | 10850 |
22 |
| F. Hoffmann-La Roche AG | 7921 |
22 |
| Boehringer Ingelheim International GmbH | 4648 |
21 |
| President and Fellows of Harvard College | 5976 |
21 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3366 |
21 |
| Pfizer Inc. | 3381 |
20 |
| Takeda Pharmaceutical Company Limited | 2709 |
20 |
| The University of North Carolina at Chapel Hill | 2039 |
20 |
| AstraZeneca AB | 2908 |
19 |
| Incyte Corporation | 1024 |
19 |
| Merck Sharp & Dohme Corp. | 2190 |
18 |
| Daiichi Sankyo Company, Limited | 1874 |
17 |
| Other owners | 5771 |